Aldesleukin Completed Phase 1 Trials for Ovarian Cancer Metastatic Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02482090TIL Therapy for Metastatic Ovarian Cancer